Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: Of 31 patients 4 (13%) had development of submucosal calcifications in the bladder neck/urethra. All 4 patients had received multiple injections of glutaraldehyde cross-linked collagen for incontinence secondary to neurogenic bladder. The calcifications were confirmed surgically. Pathology reports available for 2 of 4 patients showed chronic inflammation without dysplasia or malignant changes. Mean followup was significantly different between calcified and noncalcified cases (10.3 vs 7.2 years, p = 0.009), as was total volume of collagen injected (21 vs 12 cc, p = 0.012). Mean time to diagnosis of calcifications was 8.8 years (range 7 to 11) after first injection. A total of 24 patients without calcification underwent bladder imaging at a mean of 6.8 years (+/-2.2) after glutaraldehyde cross-linked collagen injection, which was not significantly different than the time to diagnosis (p = 0.089). The number of injections was not significantly different between the 2 groups (p = 0.426). CONCLUSIONS:
|
Authors | Matthew J Knudson, Christopher S Cooper, Craig A Block, Charles E Hawtrey, J Christopher Austin |
Journal | The Journal of urology
(J Urol)
Vol. 176
Issue 3
Pg. 1143-6; discussion 1146
(Sep 2006)
ISSN: 0022-5347 [Print] United States |
PMID | 16890711
(Publication Type: Journal Article)
|
Chemical References |
- glutaraldehyde-cross-linked collagen
- Collagen
|
Topics |
- Adolescent
- Calcinosis
(etiology)
- Child
- Child, Preschool
- Collagen
(administration & dosage, adverse effects)
- Female
- Humans
- Injections
- Male
- Prostheses and Implants
(adverse effects)
- Retrospective Studies
- Time Factors
- Urinary Bladder Diseases
(etiology)
- Urinary Incontinence
(therapy)
|